🇳🇴
NordicsNorway
Norway's biotech sector is concentrated in Oslo, with strong expertise in radiopharmaceuticals, diagnostics, and immunotherapy. Companies like Algeta (acquired by Bayer for $2.9B) have proven the Norwegian ecosystem can produce world-class biotech.
Biotech Market Cap
$914.0M
Public Companies
9
Total Companies
53
30D Performance
-4.48%
BIOTECH MARKET CAP INDEX
$914.0M+600.1%ALL
BIOTECH HUBS
OsloBergenTrondheimTromsø
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $182.6B |
| 2 |  | $244.8M |
| 3 |  | $173.8M |
| 4 |  | $114.3M |
| 5 |  | $111.6M |
| 6 |  | $107.5M |
| 7 |  | $63.9M |
| 8 |  | $48.6M |
| 9 |  | $26.7M |
| 10 |  | $22.9M |
| 11 |  | — |
| 12 |  | — |
| 13 |  | — |
| 14 |  | — |
| 15 |  | — |
| 16 |  | — |
| 17 |  | — |
| 18 |  | — |
| 19 | | — |
| 20 |  | — |
1–20 of 53
Page 1 of 3